Minn. Pension Fund Seeks Pfizer Price Drop

Managers of Minnesota's $43-billion pension fund propose a shareholder resolution that would require drug giant Pfizer to lower prescription drug prices in the United States. Critics say the effort could backfire, harming Pfizer's stock price and lowering the value of the state's retiree pension fund. Minnesota Public Radio's Tom Scheck reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: